ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 645817 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 645817; 2) Community: the network communities that were significantly associated with the response to NSC 645817; 3) Molecule: the relationships between components within communities and NSC 645817; 4) MDR: the compounds that were significantly associated with the NSC 645817.

NSC Compound Enrichment Correlation
NSC 619102 4-Methoxy-1,5-benzothiazepine-1,1-dioxide 0.0278435641331422 0.15182508
NSC 624153 Null 0.0278435641331422 0.17574766
NSC 624172 Null 0.0278435641331422 0.17354181
NSC 625496 Null 0.0278435641331422 0.10697831
NSC 627744 Null 0.0278435641331422 0.24946709
NSC 630608 Null 0.0278435641331422 0.2120949
NSC 637993 6H-Imidazo[4,5,1-de]acridin-6-one, 5-[2-(diethylamino) ethylamino]-8-methoxy-1-methyl-, dihydrochloride 0.0278435641331422 0.58141763
NSC 638634 4-Piperidinone, 3,5-bis(phenylmethylene)-1-(1-oxo-3-phenyl- 2-propenyl)- 0.0278435641331422 0.21446454
NSC 642049 Acetamide, N-(3-acetylphenyl)-2-[(4-amino-5-mercapto- 4H-1,2,4-triazol-3-yl)hydrazino]-2-oxo- 0.0278435641331422 -0.088856184
NSC 645317 Sanguilutine pseudobase 0.0278435641331422 0.30915128
Total:170  Current:120    [First] [Prev] [Next] [Last]